FIGS (NYSE:FIGS – Get Free Report) issued its quarterly earnings results on Thursday. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.07 by $0.03, FiscalAI reports. FIGS had a return on equity of 14.78% and a net margin of 9.67%. The firm had revenue of $190.69 million during the quarter, compared to the consensus estimate of $182.82 million. During the same quarter in the prior year, the business posted $0.05 earnings per share. FIGS’s revenue for the quarter was up 25.7% on a year-over-year basis.
Here are the key takeaways from FIGS’s conference call:
- Q3 net revenue rose 26% to $190.7 million, while adjusted EBITDA margin expanded 410 basis points to 16.5%. Active customers, average order value, and revenue per active customer also grew.
- FIGS raised its full-year 2026 revenue growth outlook to approximately 23.5% and adjusted EBITDA margin outlook to 15.8%; it expects Q4 revenue growth of about 15%, despite a difficult comparison with last year.
- Growth was broad-based, with international revenue up 51%, scrubwear up 24%, and non-scrubwear up 35%. Management also cited customer and brand indicators, Community Hubs, and TEAMS partnerships as potential growth drivers.
- Supplier disruption and the ongoing Jordan-related WRO have constrained inventory and caused stockouts, particularly in limited-edition products. The company expects the greatest impact in Q4, with some effects continuing through Q2 2027; it is adding Vietnam capacity and plans to begin Indonesia production.
- Management said 2026 gross margin benefited by about 250 basis points from one-time tariff refunds, which will create a year-over-year headwind in 2027. It expects normalized gross margin to be around 67.5%, while monitoring sourcing and freight costs.
FIGS Price Performance
Shares of NYSE:FIGS traded down $0.25 during trading on Friday, reaching $19.96. 7,430,912 shares of the company’s stock traded hands, compared to its average volume of 4,536,684. The stock has a market capitalization of $3.32 billion, a P/E ratio of 52.53 and a beta of 1.05. FIGS has a 12 month low of $8.00 and a 12 month high of $22.46. The company has a 50 day moving average of $16.34 and a 200-day moving average of $13.64.
Wall Street Analysts Forecast Growth
FIGS has been the subject of several research analyst reports. Wall Street Zen cut FIGS from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Barclays raised their price target on shares of FIGS from $20.00 to $24.00 and gave the stock an “overweight” rating in a research report on Tuesday. Telsey Advisory Group dropped their price target on shares of FIGS from $17.00 to $16.00 and set a “market perform” rating for the company in a research note on Friday, August 7th. The Goldman Sachs Group reiterated a “neutral” rating and set a $16.00 price objective on shares of FIGS in a research note on Friday, August 7th. Finally, KeyCorp raised their price objective on shares of FIGS from $20.00 to $27.00 and gave the stock an “overweight” rating in a report on Friday. Seven equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $21.14.
View Our Latest Stock Report on FIGS
Trending Headlines about FIGS
Here are the key news stories impacting FIGS this week:
- Positive Sentiment: KeyCorp raised its price target on FIGS to $27 from $20 and reiterated an “overweight” rating. The new target implies 35.3% upside from the cited $19.96 share price. KeyCorp ratings
- Positive Sentiment: FIGS reported Q3 revenue of $190.7 million, up 25.7% year over year and above the $182.8 million analyst estimate. Earnings of $0.10 per share also beat the $0.07 consensus and doubled the year-ago $0.05. Q3 earnings report
- Positive Sentiment: Management also provided optimistic revenue guidance for the next quarter, adding to the upbeat earnings report. Q3 sales and guidance article
- Negative Sentiment: A recent analysis described FIGS as “priced for perfection” after a substantial run-up, suggesting high expectations could limit further gains or magnify a disappointment. Valuation analysis
FIGS Company Profile
FIGS, Inc is a direct-to-consumer healthcare apparel and lifestyle company that designs and sells clothing and accessories for healthcare professionals. Its product portfolio includes scrubs, underscrubs, outerwear, footwear, bags and other accessories intended to combine functionality, comfort and contemporary design.
The company sells primarily through its digital platform and also operates retail locations and other distribution channels. FIGS serves healthcare professionals in the United States and select international markets, including Canada, the United Kingdom and Australia.
FIGS was founded in 2013 by Heather Hasson and Trina Spear.
Further Reading
- Five stocks we like better than FIGS
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for FIGS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FIGS and related companies with MarketBeat.com's FREE daily email newsletter.
